RE:RE:RE:RE:RE:USA Inflation Reduction Act (IRA) 2022 Re: Biotech and ChinaIn January 2024 the European Commission has granted marketing authorisation for Roche's Tecentriq® SC (atezolizumab), the European Union (EU)’s first PD-(L)1 cancer immunotherapy for subcutaneous (under the skin) injection.
https://www.globenewswire.com/news-release/2024/01/16/2809494/0/en/European-Commission-approves-Roche-s-Tecentriq-SC-the-EU-s-first-PD-L-1-cancer-immunotherapy-subcutaneous-injection-for-multiple-cancer-types.html
WuXi Biologics provides industry-leading and state-of-the-art drug product (DP) development services for biologics, vaccines and small molecule parenterals WuXi Apptec is in small-molecule medicinal chemistry.
https://www.axios.com/2024/02/06/china-biotech-house-field-hearing